Skip to main content

Targeting the endocannabinoid system to understand brain phsysiological and pathological processes

RYC-2017-21776

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Incorporación
Call Ramón y Cajal
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO INSTITUT HOSPITAL DEL MAR D'INVESTIGACIONS MEDIQUES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Specific hippocampal interneurons shape consolidation of recognition memory

  • Oliveira da Cruz, Jose F.
  • Busquets Garcia, Arnau, 1985-
  • Zhao, Zhe
  • Varilh, Marjorie
  • Lavanco, Gianluca
  • Robin, Laurie
  • Cannich, Astrid
  • Julio-Kalajzić, Francisca
  • Lesté-Lasserre, Thierry
  • Maître, Marlène
  • Drago, Filippo
  • Marsicano, Giovanni
  • Soria-Gómez, Edgar
A complex array of inhibitory interneurons tightly controls hippocampal activity, but how such diversity specifically affects memory processes is not well understood. We find that a small subclass of type 1 cannabinoid receptor (CB1R)-expressing hippocampal interneurons determines episodic-like memory consolidation by linking dopamine D1 receptor (D1R) signaling to GABAergic transmission. Mice lacking CB1Rs in D1-positive cells (D1-CB1-KO) display impairment in long-term, but not short-term, novel object recognition memory (NOR). Re-expression of CB1Rs in hippocampal D1R-positive cells rescues this NOR deficit. Learning induces an enhancement of in vivo hippocampal long-term potentiation (LTP), which is absent in mutant mice. CB1R-mediated NOR and the associated LTP facilitation involve local control of GABAergic inhibition in a D1-dependent manner. This study reveals that hippocampal CB1R-/D1R-expressing interneurons control NOR memory, identifying a mechanism linking the diversity of hippocampal interneurons to specific behavioral outcomes., We thank Delphine Gonzales, Nathalie Aubailly, and the personnel of the Animal Facilities of the NeuroCentre Magendie for mouse care. We thank the Biochemistry Platform of Bordeaux NeuroCampus and the members of Marsicano’s lab for useful discussions. This work was funded by INSERM; the European Research Council (Endofood ERC-2010-StG-260515, CannaPreg ERC-2014-PoC-640923, and MiCaBra ERC-2017-AdG-786467 to G.M.); Fondation pour la Recherche Medicale (FRM; DRM20101220445 to G.M. and DT20160435664 to J.F.O.d.C.); the Human Frontiers Science Program, Region Aquitaine, Agence Nationale de la Recherche (ANR; NeuroNutriSens ANR-13-BSV4-0006, ORUPS ANR-16-CE37-0010-01, and CaCoVi ANR-18-CE16-0001-02 to G.M.); BRAIN ANR-10-LABX-0043 (to G.M.); NIH/NIDA (1R21DA037678-01); the European Regional Development Fund; the European Union Horizon 2020 Research and Innovation Program (grant agreement 686009); French State/Agence Nationale de la Recherche/IdEx (ANR-10-IDEX-03-02), Eu-Fp7 (FP7-PEOPLE-2013-IEF-623638), and MINECO/AEI (RYC-2017-21776) (to A.B.-G.); FRM (ARF20140129235 to L.B.); and Ikerbasque (The Basque Foundation for Science) and MINECO (Ministerio de Economía y Competitividad) PGC2018-093990-A-I00 (MICIU/AEI/FEDER, UE) (to E.S.-G.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Astroglial cannabinoid signaling and behavior

  • Ramon Duaso, Carla, 1987-
  • Conde-Moro, Ana Rocio
  • Busquets Garcia, Arnau, 1985-
In neuroscience, the explosion of innovative and advanced technical accomplishments is fundamental to understanding brain functioning. For example, the possibility to distinguish glial and neuronal activities at the synaptic level and/or the appearance of new genetic tools to specifically monitor and manipulate astroglial functions revealed that astrocytes are involved in several facets of behavioral control. In this sense, the discovery of functional presence of type-1 cannabinoid receptors in astrocytes has led to identify important behavioral responses mediated by this specific pool of cannabinoid receptors. Thus, astroglial type-1 cannabinoid receptors are in the perfect place to play a role in a complex scenario in which astrocytes sense neuronal activity, release gliotransmitters and modulate the activity of other neurons, ultimately controlling behavioral responses. In this review, we will describe the known behavioral implications of astroglial cannabinoid signaling and highlight exciting unexplored research avenues on how astroglial cannabinoid signaling could affect behavior., The authors would like to acknowledge the rest of the “Cell-type mechanisms in normal and pathological behavior” Research Group for their support and for the constant scientific discussion in the group. This work was supported by the IBRO Return Home Fellowships 2019 and the ERC starting Grant (HighMemory, #948217) received by ABG. A. Busquets-Garcia is a Ramon y Cajal researcher (RYC-2017-21776, funded by MCIN/AEI/10.13039/501100011033 and FSE).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Glucose metabolism links astroglial mitochondria to cannabinoid effects

  • Jimenez-Blasco, Daniel
  • Busquets-Garcia, Arnau
  • Hebert-Chatelain, Etienne
  • Serrat, Roman
  • Vicente-Gutiérrez, Carlos
  • Ioannidou, Christina
  • Gómez-Sotres, Paula
  • López-Fabuel, Irene
  • Resch-Beusher, Monica
  • Resel, Eva
  • Arnouil, Dorian
  • Saraswat, Dave
  • Varilh, Marjorie
  • Cannich, Astrid
  • Julio-Kalajzic, Francisca
  • Bonilla-Del Río, Itziar
  • Almeida, Angeles
  • Puente, Nagore
  • Achicallende, Svein
  • López-Rodríguez, María L.
  • Jollé, Charlotte
  • Déglon, Nicole
  • Pellerin, Luc
  • Josephine, Charlene
  • Bonvento, Gilles
  • Panatier, Aude
  • Lutz, Beat
  • Piazza, Pier Vincenzo
  • Guzmán, Manuel
  • Bellocchio, Luigi
  • Bouzier-Sore, Anne-Karine
  • Grandes, Pedro
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Astrocytes take up glucose from the bloodstream to provide energy to the brain, thereby allowing neuronal activity and behavioural responses1,2,3,4,5. By contrast, astrocytes are under neuronal control through specific neurotransmitter receptors5,6,7. However, whether the activation of astroglial receptors can directly regulate cellular glucose metabolism to eventually modulate behavioural responses is unclear. Here we show that activation of mouse astroglial type-1 cannabinoid receptors associated with mitochondrial membranes (mtCB1) hampers the metabolism of glucose and the production of lactate in the brain, resulting in altered neuronal functions and, in turn, impaired behavioural responses in social interaction assays. Specifically, activation of astroglial mtCB1 receptors reduces the phosphorylation of the mitochondrial complex I subunit NDUFS4, which decreases the stability and activity of complex I. This leads to a reduction in the generation of reactive oxygen species by astrocytes and affects the glycolytic production of lactate through the hypoxia-inducible factor 1 pathway, eventually resulting in neuronal redox stress and impairment of behavioural responses in social interaction assays. Genetic and pharmacological correction of each of these effects abolishes the effect of cannabinoid treatment on the observed behaviour. These findings suggest that mtCB1 receptor signalling can directly regulate astroglial glucose metabolism to fine-tune neuronal activity and behaviour in mice., This work was funded by: INSERM, the European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine and Agence Nationale de la Recherche (ANR; NeuroNutriSens ANR-13-BSV4-0006, CaCoVi ANR 18-CE16-0001-02, MitObesity ANR 18-CE14-0029-01, ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043) (to G.M.); NIH/NIDA (1R21DA037678-01), Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2016-78114-R and RED2018-102576-T), Instituto de Salud Carlos III (CB16/10/00282), an EU BATCure grant (666918), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Biomedicina 2017 Fundación BBVA and Fundación Ramón Areces (to J.P.B.); Instituto de Salud Carlos III (PI18/00285; RD16/0019/0018), the European Regional Development Fund, the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement 686009), Junta de Castilla y León (IES007P17) and Fundación Ramón Areces to (A.A.); French State/ANR/IdEx (ANR-10-IDEX-03-02), Eu-Fp7 (FP7-PEOPLE-2013-IEF-623638) and Ramon y Cajal Investigator Program (RYC-2017-21776) (to A.B.-G.); FRM (SPF20121226369) (to R.S.); FRM (ARF20140129235) (to L.B.); Spanish Ministry of Science, Innovation and Universities (MCINU/FEDER; grants SAF2015-64945-R and RTI2018-095311-B-I00) (to M.G.); Canada Research Chair, Alzheimer Society of Canada—Brain Canada (17-09), Natural Sciences and Engineering Research Council (RGPIN-2015-05880), Canadian Breast Cancer Foundation (2015-317342), Canadian Health Research Institute (CIHR, 388808), New Brunswick Innovation Foundation, New Brunswick Health Research Foundation and Université de Moncton (to E.H.-C.); Basque Government (IT1230-19), Red de Trastornos Adictivos, Instituto de Salud Carlos III (ISC-III), European Regional Development Funds-European Union (ERDF-EU; RD16/0017/0012) and MINECO/FEDER, UE (SAF2015-65034-R) (to P.G.); University of the Basque Country PhD contract (PIF 16/251) (to S.A.); POP contract (BES-2016-076766, BES-C-2016-0051) (to I.B.-D.R.); French State/ANR (ANR-10-IDEX and TRAIL ANR-10-LABX-57); French-Swiss ANR-FNS (ANR-15- CE37-0012) (to A.-K.B.-S.); SFB/TRR 58 ‘Fear, anxiety, anxiety disorders’ (subproject A04); and CRC 1193 ‘Neurobiology of resilience’ (subproject B04) (to B.L.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolic Messengers: endocannabinoids

  • Busquets-Garcia, Arnau
  • Bolaños, Juan P.
  • Marsicano, Giovanni
Endocannabinoid signalling is considered one of the most important modulatory systems in a whole organism. Research has yielded great insight on the mechanisms that link endocannabinoids and metabolic functions. Here, we provide a brief overview of the metabolic roles of endocannabinoids in tissue, cellular and subcellular-dependent mechanisms. In general, we point out how the central and peripheral control of body energy metabolism likely represents the main function of type-1 cannabinoid receptors. More specifically, we focus on recent advances underlying mechanisms of endocannabinoid control of cell metabolism through the modulation of the functions of specific organelles. While highlighting a historical summary and summarizing past discoveries, this short review aims at proposing future open questions for a field that does not stop surprising researchers with unexpected and exciting discoveries., We also thank all the members of A.B.-G.’s, J.P.B.’s and G.M.’s labs for useful discussions and for their invaluable support. The work of A.B.-G. is supported by: Agencia Estatal de Investigación-FEDER (RTI2018-093667-A-100); the ERC starting Grant (HighMemory, #948217); the IBRO Return Home Fellowships 2019 and the Ramon y Cajal programme (RYC-2017-21776) funded by MCIN/ AEI/10.13039/501100011033 and FSE). The work of J.P.B. is funded by the Agencia Estatal de Investigación (PID2019-105699RB-I00; PDC2021-121013-I00; RED2018‐102576‐T; MCIN/AEI/10.13039/501100011033 & European Union NextGenerationEU/PRTR), Plan Nacional de Drogas (Ministerio de Sanidad; 2020I028) and Junta de Castilla y León (CS/151P20 and Escalera de Excelencia CLU-2017-03). The work of G.M. is funded by: INSERM, European Research Council (Endofood, ERC–2010–StG–260515 and CannaPreg, ERC-2014-PoC-640923, MiCaBra, ERC-2017-AdG-786467), Fondation pour la Recherche Medicale (FRM, DRM20101220445), the Human Frontiers Science Program, Region Nouvelle Aquitaine, Agence Nationale de la Recherche (ANR, NeuroNutriSens ANR-13-BSV4-0006 and ORUPS ANR-16-CE37-0010-01 and BRAIN ANR-10-LABX-0043).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Specific hippocampal interneurons shape consolidation of recognition memory

  • Oliveira da Cruz, Jose F.
  • Busquets Garcia, Arnau, 1985-
  • Zhao, Zhe
  • Varilh, Marjorie
  • Lavanco, Gianluca
  • Robin, Laurie
  • Cannich, Astrid
  • Julio-Kalajzić, Francisca
  • Lesté-Lasserre, Thierry
  • Maître, Marlène
  • Drago, Filippo
  • Marsicano, Giovanni
  • Soria-Gómez, Edgar
A complex array of inhibitory interneurons tightly controls hippocampal activity, but how such diversity specifically affects memory processes is not well understood. We find that a small subclass of type 1 cannabinoid receptor (CB1R)-expressing hippocampal interneurons determines episodic-like memory consolidation by linking dopamine D1 receptor (D1R) signaling to GABAergic transmission. Mice lacking CB1Rs in D1-positive cells (D1-CB1-KO) display impairment in long-term, but not short-term, novel object recognition memory (NOR). Re-expression of CB1Rs in hippocampal D1R-positive cells rescues this NOR deficit. Learning induces an enhancement of in vivo hippocampal long-term potentiation (LTP), which is absent in mutant mice. CB1R-mediated NOR and the associated LTP facilitation involve local control of GABAergic inhibition in a D1-dependent manner. This study reveals that hippocampal CB1R-/D1R-expressing interneurons control NOR memory, identifying a mechanism linking the diversity of hippocampal interneurons to specific behavioral outcomes., We thank Delphine Gonzales, Nathalie Aubailly, and the personnel of the Animal Facilities of the NeuroCentre Magendie for mouse care. We thank the Biochemistry Platform of Bordeaux NeuroCampus and the members of Marsicano’s lab for useful discussions. This work was funded by INSERM; the European Research Council (Endofood ERC-2010-StG-260515, CannaPreg ERC-2014-PoC-640923, and MiCaBra ERC-2017-AdG-786467 to G.M.); Fondation pour la Recherche Medicale (FRM; DRM20101220445 to G.M. and DT20160435664 to J.F.O.d.C.); the Human Frontiers Science Program, Region Aquitaine, Agence Nationale de la Recherche (ANR; NeuroNutriSens ANR-13-BSV4-0006, ORUPS ANR-16-CE37-0010-01, and CaCoVi ANR-18-CE16-0001-02 to G.M.); BRAIN ANR-10-LABX-0043 (to G.M.); NIH/NIDA (1R21DA037678-01); the European Regional Development Fund; the European Union Horizon 2020 Research and Innovation Program (grant agreement 686009); French State/Agence Nationale de la Recherche/IdEx (ANR-10-IDEX-03-02), Eu-Fp7 (FP7-PEOPLE-2013-IEF-623638), and MINECO/AEI (RYC-2017-21776) (to A.B.-G.); FRM (ARF20140129235 to L.B.); and Ikerbasque (The Basque Foundation for Science) and MINECO (Ministerio de Economía y Competitividad) PGC2018-093990-A-I00 (MICIU/AEI/FEDER, UE) (to E.S.-G.).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Astroglial cannabinoid signaling and behavior

  • Ramon Duaso, Carla, 1987-
  • Conde-Moro, Ana Rocio
  • Busquets Garcia, Arnau, 1985-
In neuroscience, the explosion of innovative and advanced technical accomplishments is fundamental to understanding brain functioning. For example, the possibility to distinguish glial and neuronal activities at the synaptic level and/or the appearance of new genetic tools to specifically monitor and manipulate astroglial functions revealed that astrocytes are involved in several facets of behavioral control. In this sense, the discovery of functional presence of type-1 cannabinoid receptors in astrocytes has led to identify important behavioral responses mediated by this specific pool of cannabinoid receptors. Thus, astroglial type-1 cannabinoid receptors are in the perfect place to play a role in a complex scenario in which astrocytes sense neuronal activity, release gliotransmitters and modulate the activity of other neurons, ultimately controlling behavioral responses. In this review, we will describe the known behavioral implications of astroglial cannabinoid signaling and highlight exciting unexplored research avenues on how astroglial cannabinoid signaling could affect behavior., The authors would like to acknowledge the rest of the “Cell-type mechanisms in normal and pathological behavior” Research Group for their support and for the constant scientific discussion in the group. This work was supported by the IBRO Return Home Fellowships 2019 and the ERC starting Grant (HighMemory, #948217) received by ABG. A. Busquets-Garcia is a Ramon y Cajal researcher (RYC-2017-21776, funded by MCIN/AEI/10.13039/501100011033 and FSE).